However, the detection of CD38 can be useful to identify leukemic stem cells (LSC) in AML, especially of the types minimally differentiated (M0) and without maturation (M1), but also in the heterogeneous leukemic cell population of AML CD19(+). The gene discussed is CD38; the disease is acute myeloid leukemia.